December 21, 2016
Hansa Medical successfully completes Phase II IdeS study; QUITS IdeS study in acquired TTP
Hansa Medical AB has announced completion of a Phase II study entitled “A Phase II Study to Evaluate the Safety,…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Hansa Medical
December 15, 2016
COMP gives positive opinion on Hansa Medical’s orphan drug
Hansa Medical, a biopharmaceutical company focusing on novel immunomodulatory enzymes, has announced that the Committee for Orphan Medicinal Products (COMP)…